UroGen Pharma (URGN) PT Lowered to $34 at Oppenheimer
Tweet
Share
E-mailGet Alerts URGN Hot Sheet
Price: $44.88 +1.04%
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 2 | New: 0
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 2 | New: 0
Join SI Premium – FREE
Oppenheimer analyst Leland Gershell lowered the price target on UroGen Pharma (NASDAQ: URGN) to $34.00 (from $40.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Telenor ASA (TEL:NO) (TELNY) to Neutral
- Morgan Stanley Upgrades Shell PLC (SHEL:LN) (SHEL) to Overweight
- DHL Group (DHL:GR) PT Raised to EUR55 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
